NovoCure Ltd | Business Contracts

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 23, 2023)

Non-Employee Director Compensation Program (Filed With SEC on July 28, 2022)

Clinical Trial Collaboration and Supply Agreement dated May 18 (Filed With SEC on May 26, 2022)

Amendment No. 1 dated as of December 6, 2021 to Credit Agreement dated as of November 6 (Filed With SEC on February 24, 2022)

Employment Agreement, dated as of April 1, 2022, by and between NovoCure USA LLC and Todd Longsworth (Filed With SEC on April 7, 2022)

Construction Agreement dated December 30, 2021 by and between Hanover Development Corporation and Novocure Inc (Filed With SEC on February 24, 2022)

Purchase and Sale Agreement dated December 1, 2021 by and between 64 Vaughan Mall, LLC and Novocure Inc (Filed With SEC on February 24, 2022)

Non-Employee Director Compensation Program (Filed With SEC on April 29, 2021)

Employment Agreement, dated as of February 3, 2017 by and between Novocure USA LLC and Todd Longsworth (Filed With SEC on April 29, 2021)

Amendment #1 to Employment Agreement between Novocure USA LLC and William F. Doyle dated February 24, 2021 (Filed With SEC on February 25, 2021)

First Addendum dated June 9, 2020 to License and Collaboration Agreement, dated as of September 10, 2018, between NovoCure Limited and Zai Lab (Shanghai) Co., Ltd (Filed With SEC on February 25, 2021)

Credit Agreement dated November 6, 2020 among NovoCure Limited, the subsidiary borrowers party thereto, the lenders party thereto and J.P. Morgan Chase Bank, N.A., as... (Filed With SEC on November 9, 2020)

Indenture, dated November 5 (Filed With SEC on November 5, 2020)

Employment Agreement, dated as of September 1, 2020, by and between Michael Ambrogi and Novocure USA LLC (Filed With SEC on August 13, 2020)

Employment Agreement, dated as of September 1, 2020, by and between Ashley Cordova and Novocure USA LLC (Filed With SEC on August 13, 2020)

Employment Agreement, dated as of September 1, 2020, by and between Wilco Groenhuysen and Novocure USA LLC (Filed With SEC on August 13, 2020)

Form of Performance-Based Share Unit Award for Certain Executive Officers (Filed With SEC on March 6, 2020)

Form of Performance-Based Share Unit Award for Executive Chairman and Chief Executive Officer (Filed With SEC on March 6, 2020)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 27, 2020)

Non-Employee Director Compensation Program (Filed With SEC on July 25, 2019)

Form of Non-Qualified Stock Option Agreement for Employees in Austria (Filed With SEC on May 2, 2019)

Form of Non-Qualified Stock Option Agreement for Employees in Sweden (Filed With SEC on May 2, 2019)

Form of Restricted Share Unit Award Notice for Employees in Sweden (Filed With SEC on May 2, 2019)

Form of Restricted Share Unit Award Notice for Employees in Austria (Filed With SEC on May 2, 2019)

NovoCure Ltd (24)